Rankings
▼
Calendar
ESPR FY 2011 Earnings — Esperion Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ESPR
Esperion Therapeutics, Inc.
$501M
FY 2011 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$10M
Net Income
-$11M
EPS (Diluted)
$-1.13
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$9M
Stock-Based Comp.
$78,451
Balance Sheet
Total Assets
$2M
Total Liabilities
$8M
Stockholders' Equity
-$6M
Cash & Equivalents
$2M
← FY 2002
All Quarters
FY 2012 →
